The discovery that the identification and biopsy of the first lymph node to which a cancer spreads (the sentinel node) can lead to more accurate diagnosis and treatment has revolutionised the management of breast cancer. Now a team of researchers has been able to identify accurately the sentinel node (SN) in head and neck squamous cell carcinoma (HNSCC) using a novel tracer; a challenging task because there are up to 150 different lymph nodes in the neck, and the differentiation of true SNs from secondary nodes is difficult. The study, to be reported today (Friday) to the 5th International Conference on Innovative Approaches in Head and Neck Oncology (ICHNO) will reduce significantly the number of HNSCC patients who currently undergo selective neck dissection (SND), a procedure which involves removing a group of lymph nodes from the neck in order to try to eradicate those which may have been reached by the cancer.
"Until recently, surgeons had little choice but to carry out en-bloc surgery of all the soft tissue in a lymph node region, with all the after effects that this entailed for the patient. SN detection and biopsy using conventional tracers may be difficult for some tumour sites, potentially limiting its use. Our current multi-centre pivotal study has shown that in many patients, by using a radiotracer with a novel receptor-based mechanism, the SN can be reliably identified and removed for biopsy without having to undertake more extensive surgery. This means that only patients with metastatic SNs would require extensive surgical treatment," says Professor Remco de Bree, a head and neck surgeon from the VU University Medical Center, Amsterdam, The Netherlands.
Colleagues from the USA carried out a trial in which 83 patients with early stage HNSCC who were all scheduled to undergo neck dissection were injected with the novel tracer, tilmanocept. They were able to identify and remove at least one SN in 81 patients. When the results were compared with studies in the literature using standard radiocolloid tracers the researchers found that the SN biopsy using tilmanocept provided a high identification rate and low false negative rate for SNs, thus facilitating accurate prediction of the spread of the cancer.
"Not only was the detection rate of sentinel nodes by tilmanocept high, but it also has other advantages," Prof de Bree will say. "It is retained longer in the sentinel node - for up to 30 hours - and clears faster from the injection site. These advantages are not confined solely to HNSCC; the tracer may be particularly helpful where the injection site is located very close to the sentinel node, and also in other tumour locations."
The researchers now plan to start a study in the EU in which patients will undergo SN mapping (lymphoscintigraphy) after injection of both types of radiotracers. "If we find that lymphoscintigrams using tilmanocept are at least as good as the conventional radiocolloid tracer in identification and visualization of sentinel nodes, we would like to see a randomised clinical trial involving large numbers of patients," says Prof de Bree.
Avoiding unnecessary neck dissection is important, not only because of the desire to minimise surgery, but also because the surgery can have significant negative after effects. Even in selective node dissection, which is carried out in early stage cancer and in which fewer lymph nodes need to be removed, these negative effects can be considerable. The most common is decreased shoulder mobility with associated pain, but there may also be difficulty in talking or swallowing, and permanent nerve damage and numbness on the side where the surgery has been carried out.
"We believe that we have made an important step forward in minimising post-operative complications for patient with early HNSCC, enabling a more accurate identification of the stage of their disease, and reducing the cost to healthcare systems at the same time," Prof de Bree will conclude.
Professor Jean Bourhis, co-chair of the conference scientific committee, said: "Finding means to minimise the impact of any surgery is important, and particularly so in patients with cancer. This research represents a significant step forward in reducing the complications caused by neck dissection in patients with head and neck tumours."
Explore further: Which breast cancer patients need lymph nodes removed? Ultrasound narrows it down
Medical Xpress on facebook
Related Stories
Which breast cancer patients need lymph nodes removed? Ultrasound narrows it down
Feb 02, 2015
Which breast cancer patients need to have underarm lymph nodes removed? Mayo Clinic-led research is narrowing it down. A new study finds that not all women with lymph node-positive breast cancer treated with chemotherapy ...
Sentinel node biopsy safe, effective in head and neck melanomas
Aug 05, 2011
A common technique for determining whether melanoma has spread can be used safely and effectively even in tumors from the head and neck area, according to a new study from the University of Michigan Comprehensive Cancer Center. ...
Breast cancer patients with positive ultrasound guided axillary node biopsy need dissection
May 03, 2012
Contrary to a trend in treatment, breast cancer patients with suspicious lymph nodes should have an ultrasound-guided axillary node biopsy, and if that biopsy is positive these patients should undergo an axillary dissection, ...
Less invasive surgery detects residual breast cancer in lymph nodes after chemotherapy
Dec 05, 2012
Most patients whose breast cancer has spread to their lymph nodes have most of the lymph nodes in their armpit area removed after chemotherapy to see if any cancer remains. A study conducted through the American College of ...
Less can be more when removing lymph nodes during breast cancer surgery
Oct 01, 2013
A conservative approach to removing lymph nodes is associated with less harm for breast cancer patients and often yields the same results as more radical procedures, researchers at UT Southwestern Medical Center have found.
Recommended for you
Mammography rates down since 2009 USPSTF guidelines
9 hours ago
(HealthDay)—Since the publication of the U.S. Preventive Services Task Force guidelines for mammography in 2009, there has been a decrease in mammography rates among white, Hispanic, and Asian women, according ...
Two cell-signaling molecules found to suppress the spread of melanoma
14 hours ago
In what is believed to be the largest epigenetic analysis to date of cell-signaling molecules in early-stage melanoma, researchers at NYU Langone Medical Center and its Laura and Isaac Perlmutter Cancer Center have identified ...
Fatal cancer found among Southern Nevada residents likely caused by asbestos in nature
15 hours ago
Southern Nevada counties that include Las Vegas show high proportions of women and younger residents coming down with a rare and aggressive cancer more commonly found in older men occupationally exposed to ...
Researchers design 'evolutionary trap' to thwart drug resistance
15 hours ago
Cancer is a notoriously evasive disease. It can adopt multiple identities, accumulating mutations or even gaining or losing whole chromosomes to create genetic variants of itself that are resistant to whatever ...
Estimates of gastric, breast cancer risk in carriers of CDH1 gene mutations
16 hours ago
More precise estimates of age-associated risks of gastric and breast cancer were derived for carriers of the CDH1 gene mutation, a cancer predisposing gene that is abnormal in families meeting criteria for clinically defined ...
Cancer patients rarely demand unnecessary tests and treatments
16 hours ago
Physicians often blame patient demands for contributing to high medical costs, however, a new study involving more than 5,000 patient-clinician visits indicates that cancer patients rarely push for unnecessary tests and treatments ...
User comments
Please sign in to add a comment. Registration is free, and takes less than a minute. Read more
Click here to reset your password.
Sign in to get notified via email when new comments are made.
© Medical Xpress 2011-2014, Science X network
The discovery that the identification and biopsy of the first lymph node to which a cancer spreads (the sentinel node) can lead to more accurate diagnosis and treatment has revolutionised the management of breast cancer. Now a team of researchers has been able to identify accurately the sentinel node (SN) in head and neck squamous cell carcinoma (HNSCC) using a novel tracer; a challenging task because there are up to 150 different lymph nodes in the neck, and the differentiation of true SNs from secondary nodes is difficult. The study, to be reported today (Friday) to the 5th International Conference on Innovative Approaches in Head and Neck Oncology (ICHNO) will reduce significantly the number of HNSCC patients who currently undergo selective neck dissection (SND), a procedure which involves removing a group of lymph nodes from the neck in order to try to eradicate those which may have been reached by the cancer.
"Until recently, surgeons had little choice but to carry out en-bloc surgery of all the soft tissue in a lymph node region, with all the after effects that this entailed for the patient. SN detection and biopsy using conventional tracers may be difficult for some tumour sites, potentially limiting its use. Our current multi-centre pivotal study has shown that in many patients, by using a radiotracer with a novel receptor-based mechanism, the SN can be reliably identified and removed for biopsy without having to undertake more extensive surgery. This means that only patients with metastatic SNs would require extensive surgical treatment," says Professor Remco de Bree, a head and neck surgeon from the VU University Medical Center, Amsterdam, The Netherlands.
Colleagues from the USA carried out a trial in which 83 patients with early stage HNSCC who were all scheduled to undergo neck dissection were injected with the novel tracer, tilmanocept. They were able to identify and remove at least one SN in 81 patients. When the results were compared with studies in the literature using standard radiocolloid tracers the researchers found that the SN biopsy using tilmanocept provided a high identification rate and low false negative rate for SNs, thus facilitating accurate prediction of the spread of the cancer.
"Not only was the detection rate of sentinel nodes by tilmanocept high, but it also has other advantages," Prof de Bree will say. "It is retained longer in the sentinel node - for up to 30 hours - and clears faster from the injection site. These advantages are not confined solely to HNSCC; the tracer may be particularly helpful where the injection site is located very close to the sentinel node, and also in other tumour locations."
The researchers now plan to start a study in the EU in which patients will undergo SN mapping (lymphoscintigraphy) after injection of both types of radiotracers. "If we find that lymphoscintigrams using tilmanocept are at least as good as the conventional radiocolloid tracer in identification and visualization of sentinel nodes, we would like to see a randomised clinical trial involving large numbers of patients," says Prof de Bree.
Avoiding unnecessary neck dissection is important, not only because of the desire to minimise surgery, but also because the surgery can have significant negative after effects. Even in selective node dissection, which is carried out in early stage cancer and in which fewer lymph nodes need to be removed, these negative effects can be considerable. The most common is decreased shoulder mobility with associated pain, but there may also be difficulty in talking or swallowing, and permanent nerve damage and numbness on the side where the surgery has been carried out.
"We believe that we have made an important step forward in minimising post-operative complications for patient with early HNSCC, enabling a more accurate identification of the stage of their disease, and reducing the cost to healthcare systems at the same time," Prof de Bree will conclude.
Professor Jean Bourhis, co-chair of the conference scientific committee, said: "Finding means to minimise the impact of any surgery is important, and particularly so in patients with cancer. This research represents a significant step forward in reducing the complications caused by neck dissection in patients with head and neck tumours."
Explore further: Which breast cancer patients need lymph nodes removed? Ultrasound narrows it down
Medical Xpress on facebook
Related Stories
Which breast cancer patients need lymph nodes removed? Ultrasound narrows it down
Feb 02, 2015
Which breast cancer patients need to have underarm lymph nodes removed? Mayo Clinic-led research is narrowing it down. A new study finds that not all women with lymph node-positive breast cancer treated with chemotherapy ...
Sentinel node biopsy safe, effective in head and neck melanomas
Aug 05, 2011
A common technique for determining whether melanoma has spread can be used safely and effectively even in tumors from the head and neck area, according to a new study from the University of Michigan Comprehensive Cancer Center. ...
Breast cancer patients with positive ultrasound guided axillary node biopsy need dissection
May 03, 2012
Contrary to a trend in treatment, breast cancer patients with suspicious lymph nodes should have an ultrasound-guided axillary node biopsy, and if that biopsy is positive these patients should undergo an axillary dissection, ...
Less invasive surgery detects residual breast cancer in lymph nodes after chemotherapy
Dec 05, 2012
Most patients whose breast cancer has spread to their lymph nodes have most of the lymph nodes in their armpit area removed after chemotherapy to see if any cancer remains. A study conducted through the American College of ...
Less can be more when removing lymph nodes during breast cancer surgery
Oct 01, 2013
A conservative approach to removing lymph nodes is associated with less harm for breast cancer patients and often yields the same results as more radical procedures, researchers at UT Southwestern Medical Center have found.
Recommended for you
Mammography rates down since 2009 USPSTF guidelines
9 hours ago
(HealthDay)—Since the publication of the U.S. Preventive Services Task Force guidelines for mammography in 2009, there has been a decrease in mammography rates among white, Hispanic, and Asian women, according ...
Two cell-signaling molecules found to suppress the spread of melanoma
14 hours ago
In what is believed to be the largest epigenetic analysis to date of cell-signaling molecules in early-stage melanoma, researchers at NYU Langone Medical Center and its Laura and Isaac Perlmutter Cancer Center have identified ...
Fatal cancer found among Southern Nevada residents likely caused by asbestos in nature
15 hours ago
Southern Nevada counties that include Las Vegas show high proportions of women and younger residents coming down with a rare and aggressive cancer more commonly found in older men occupationally exposed to ...
Researchers design 'evolutionary trap' to thwart drug resistance
15 hours ago
Cancer is a notoriously evasive disease. It can adopt multiple identities, accumulating mutations or even gaining or losing whole chromosomes to create genetic variants of itself that are resistant to whatever ...
Estimates of gastric, breast cancer risk in carriers of CDH1 gene mutations
16 hours ago
More precise estimates of age-associated risks of gastric and breast cancer were derived for carriers of the CDH1 gene mutation, a cancer predisposing gene that is abnormal in families meeting criteria for clinically defined ...
Cancer patients rarely demand unnecessary tests and treatments
16 hours ago
Physicians often blame patient demands for contributing to high medical costs, however, a new study involving more than 5,000 patient-clinician visits indicates that cancer patients rarely push for unnecessary tests and treatments ...
User comments
Please sign in to add a comment. Registration is free, and takes less than a minute. Read more
Click here
to reset your password.
Sign in to get notified via email when new comments are made.
© Medical Xpress 2011-2014, Science X network
0 comments:
Post a Comment